PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
2.810
-0.040 (-1.40%)
May 16, 2025, 11:59 AM - Market open
PolyPid Employees
As of December 31, 2024, PolyPid had 60 total employees, including 57 full-time and 3 part-time employees. The number of employees decreased by 2 or -3.23% compared to the previous year.
Employees
60
Change (1Y)
-2
Growth (1Y)
-3.23%
Revenue / Employee
n/a
Profits / Employee
-$514,033
Market Cap
28.64M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PYPD News
- 1 day ago - PolyPid Ltd. (PYPD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - PolyPid Provides Corporate Update and Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 17 days ago - PolyPid to Report First Quarter 2025 Financial Results and Operational Highlights on May 14, 2025 - GlobeNewsWire
- 24 days ago - PolyPid to Participate in The Citizens Life Sciences Conference - GlobeNewsWire
- 2 months ago - PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections - GlobeNewsWire
- 2 months ago - PolyPid to Participate in the 37th Annual ROTH Conference - GlobeNewsWire
- 3 months ago - PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire